Favorites Sign in
  1. Home
  2. Companies
  3. Stock Puma Biotechnology
Puma Biotechnology logo

Puma Biotechnology PBYI

$ 10.7 5.0%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 50 M

Market Cap[1]

 $ 535 M

EBITDA (LTM)

 $ 48.2 M

P/E (LTM)

 15.403226

P/S (LTM)

 2.091376

EPS (LTM)

 0.62

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
 		$ 0.64 -7.06 % $ 68.3 M Nasdaq Global Market britainBritain
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Affimed N.V. Affimed N.V.
AFMD
 		- -34.95 % $ 21.5 M Nasdaq Global Select Market,SPB germanyGermany
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
 		$ 1.71 -1.16 % $ 1.15 B Nasdaq Capital Market israelIsrael
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
 		- -1.58 % $ 28.1 M Nasdaq Global Market chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
 		- - $ 12.5 M Nasdaq Global Market belgiumBelgium
Seer Seer
SEER
 		$ 1.71 -1.45 % $ 94.4 M Nasdaq Global Select Market usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		- - $ 3.37 B Nasdaq Global Select Market chinaChina
Trevi Therapeutics Trevi Therapeutics
TRVI
 		$ 13.98 0.87 % $ 1.88 B Nasdaq Global Market usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
 		$ 19.8 0.1 % $ 2.81 B Nasdaq Global Select Market britainBritain
Soligenix Soligenix
SNGX
 		$ 0.35 -1.15 % $ 1.82 M Nasdaq Capital Market usaUSA
Spruce Biosciences Spruce Biosciences
SPRB
 		$ 46.23 7.99 % $ 35.4 M Nasdaq Global Select Market usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
 		$ 28.24 0.32 % $ 1.59 B Nasdaq Global Select Market,SPB usaUSA
Galapagos NV Galapagos NV
GLPG
 		- - $ 1.83 B Nasdaq Global Select Market belgiumBelgium
Savara Savara
SVRA
 		$ 4.66 -2.0 % $ 1.04 B Nasdaq Global Select Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
 		- -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
 		- - $ 2.91 B Nasdaq Global Select Market usaUSA
TG Therapeutics TG Therapeutics
TGTX
 		$ 61.48 1.19 % $ 8.87 B Nasdaq Capital Market usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
 		$ 0.19 11.9 % $ 7.23 M Nasdaq Global Select Market usaUSA
Aphria Inc. Aphria Inc.
APHA
 		- -0.45 % $ 4.87 B Nasdaq Global Select Market canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
 		- -0.90 % $ 104 M Nasdaq Capital Market usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
 		- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
 		$ 3.62 1.96 % $ 611 M Nasdaq Global Select Market singaporeSingapore
XBiotech XBiotech
XBIT
 		$ 1.96 -1.51 % $ 59.8 M Nasdaq Global Select Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
 		- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
 		- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
 		- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
 		- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
 		- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
 		- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
 		- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
 		- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
 		- - $ 256 M Nasdaq Global Market canadaCanada
argenx SE argenx SE
ARGX
 		$ 931.52 3.37 % $ 57.1 B Nasdaq Global Select Market niderlandNiderland
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
 		- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
 		- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
 		- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
 		- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
 		- - $ 1.77 B Nasdaq Global Select Market usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
 		- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		- - $ 1.94 B Nasdaq Capital Market canadaCanada
Exicure Exicure
XCUR
 		$ 0.99 -1.7 % $ 6.23 M Nasdaq Capital Market usaUSA
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
 		- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
 		- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
 		- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
 		- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.